Vesical Imaging-Reporting and Data System (VI-RADS) As a Grouping Imaging Biomarker Combined with a Decision-Tree Mode to Preoperatively Predict the Pathological Grade of Bladder Cancer.

B. Cao,Q. Li,P. Xu,Y. Zhang,S. Cai,S. Rao,M. Zeng,Y. Dai,S. Jiang,J. Zhou

DOI: https://doi.org/10.1016/j.crad.2024.01.031

IF: 3.389

2024-01-01

Clinical Radiology

Abstract:AIM: To investigate whether the Vesical Imaging-Reporting and Data System (VI-RADS) could be used to develop a new non-invasive preoperative grade-prediction system to partially predict high-grade bladder cancer (HG-BC). MATERIALS AND METHODS: The present study enrolled 89 primary BC patients prospectively from March 2022 to June 2023. Receiver operating characteristic (ROC) curve analysis was performed to evaluate the diagnostic performance of VI-RADS for predicting HG-BC and muscle-invasive bladder cancer (MIBC) in the entire group. In the low VI-RADS (<2) group, the decision tree-based method was used to obtain significant predictors and construct the decision-tree model (DT model). The performance of the DT model and low VI-RADS scores for predicting HG-BC was determined using ROC, calibration, and decision curve analyses. RESULTS: At a cut -off of >= 3, the specificity and positive predictive value of VI-RADS for predicting HG-BC in the entire group was 100%, and the area under the ROC curve (AUC) was 0.697. Among 65 patients with low VI-RADS scores, the DT model showed an AUC of 0.884 in predicting HG -BC compared to 0.506 for low VI-RADS scores. Calibration and decision curve analyses showed that the DT model performed better than the low VI-RADS scores. CONCLUSION: Most VI-RADS scores >= 3 correspond to HG-BCs. VI-RADS could be used as a grouping imaging biomarker for a pathological grade -prediction procedure, which in combination with the DT model for low VI-RADS (<2) populations, would provide a potential preoperative non-invasive method of predicting HG -BC. (c) 2024 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.